1. Arango Duque G, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol. 2014; 5:491.
Article
2. Bacon LD, Hunt HD, Cheng HH. A review of the development of chicken lines to resolve genes determining resistance to diseases. Poult Sci. 2000; 79:1082–1093.
Article
3. Baigent S, Davison T. Marek's disease virus: biology and life cycle. In : Davison F, Nair V, editors. Marek's Disease: An Evolving Problem. Oxford: Elsevier Academic Press;2004. p. 62–77.
4. Biggs PM. The Leeuwenhoek Lecture, 1997. Marek's disease herpesvirus: oncogenesis and prevention. Philos Trans R Soc Lond B Biol Sci. 1997; 352:1951–1962.
Article
5. Biron CA. Initial and innate responses to viral infections-pattern setting in immunity or disease. Curr Opin Microbiol. 1999; 2:374–381.
6. Blaxland JD, Macleod AJ, Hall T. Trials with Marek's disease vaccines prepared from a turkey herpes virus and an attenuated Marek's disease virus. Vet Rec. 1975; 97:50–52.
Article
7. Calnek BW. Pathogenesis of Marek's disease virus infection. Curr Top Microbiol Immunol. 2001; 255:25–55.
Article
8. Calnek BW, Adldinger HK, Kahn DE. Feather follicle epithelium: a source of enveloped and infectious cell-free herpesvirus from Marek's disease. Avian Dis. 1970; 14:219–233.
Article
9. Cerwenka A, Lanier LL. Natural killer cells, viruses and cancer. Nat Rev Immunol. 2001; 1:41–49.
Article
10. Churchill AE, Biggs PM. Agent of Marek's disease in tissue culture. Nature. 1967; 215:528–530.
Article
11. Davison F, Nair V. Marek's Disease: An Evolving Problem. The Netherlands and Boston: Elsevier Press;2004.
12. de Boer GF, Groenendal JE, Boerrigter HM, Kok GL, Pol JM. Protective efficacy of Marek's disease virus (MDV) CVI-988 CEF65 clone C against challenge infection with three very virulent MDV strains. Avian Dis. 1986; 30:276–283.
Article
13. Djeraba A, Bernardet N, Dambrine G, Quéré P. Nitric oxide inhibits Marek's disease virus replication but is not the single decisive factor in interferon-gamma-mediated viral inhibition. Virology. 2000; 277:58–65.
Article
14. Haffer K, Sevoian M, Wilder M. The role of the macrophages in Marek's disease:
in vitro and
in vivo studies. Int J Cancer. 1979; 23:648–656.
Article
15. Jarosinski KW, Tischer BK, Trapp S, Osterrieder N. Marek's disease virus: lytic replication, oncogenesis and control. Expert Rev Vaccines. 2006; 5:761–772.
Article
16. Kodama H, Mikami T, Inoue M, Izawa H. Inhibitory effects of macrophages against Marek's disease virus plaque formation in chicken kidney cell cultures. J Natl Cancer Inst. 1979; 63:1267–1271.
17. Lanier LL. Evolutionary struggles between NK cells and viruses. Nat Rev Immunol. 2008; 8:259–268.
Article
18. Lanier LL. Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol. 2008; 9:495–502.
Article
19. Lee LF, Liu X, Witter RL. Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens. J Immunol. 1983; 130:1003–1006.
20. Lee LF, Zhang H, Heidari M, Lupiani B, Reddy SM. Evaluation of factors affecting vaccine efficacy of recombinant Marek's disease virus lacking the Meq oncogene in chickens. Avian Dis. 2011; 55:172–179.
Article
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2
−ΔΔCT method. Methods. 2001; 25:402–408.
Article
22. Markowski-Grimsrud CJ, Schat KA. Cytotoxic T lymphocyte responses to Marek's disease herpesvirus-encoded glycoproteins. Vet Immunol Immunopathol. 2002; 90:133–144.
Article
23. Mast J, Goddeeris BM. Development of immunocompetence of broiler chickens. Vet Immunol Immunopathol. 1999; 70:245–256.
Article
24. Mast J, Goddeeris BM, Peeters K, Vandesande F, Berghman LR. Characterisation of chicken monocytes, macrophages and interdigitating cells by the monoclonal antibody KUL01. Vet Immunol Immunopathol. 1998; 61:343–357.
Article
25. Matikainen S, Paananen A, Miettinen M, Kurimoto M, Timonen T, Julkunen I, Sareneva T. IFN-α and IL-18 synergistically enhance IFN-γ production in human NK cells: differential regulation of Stat4 activation and IFN-γ gene expression by IFN-α and IL-12. Eur J Immunol. 2001; 31:2236–2245.
Article
26. Okazaki W, Purchase HG, Burmester BR. Protection against Marek's disease by vaccination with a herpesvirus of turkeys. Avian Dis. 1970; 14:413–429.
Article
27. Powell PC, Hartley KJ, Mustill BM, Rennie M. Studies on the role of macrophages in Marek's disease of the chicken. J Reticuloendothel Soc. 1983; 34:289–297.
28. Qureshi MA. Avian macrophage and immune response: an overview. Poult Sci. 2003; 82:691–698.
Article
29. Rispens BH, van Vloten H, Mastenbroek N, Maas HJ, Schat KA. Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials. Avian Dis. 1972; 16:108–125.
Article
30. Rispens BH, van Vloten H, Mastenbroek N, Maas JL, Schat KA. Control of Marek's disease in the Netherlands. II. Field trials on vaccination with an avirulent strain (CVI 988) of Marek's disease virus. Avian Dis. 1972; 16:126–138.
Article
31. Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol. 2002; 20:323–370.
Article
32. Schat K, Nair V. Marek's disease. In : Saif YM, Fadly AM, Glisson JR, McDougald LB, Nolan LK, Swayne DE, editors. Diseases of Poultry. Ames: Iowa State University Press;2008. p. 452–514.
33. Schat KA, Calnek BW. Characterization of an apparently nononcogenic Marek's disease virus. J Natl Cancer Inst. 1978; 60:1075–1082.
34. Sharma JM. Natural killer cell activity in chickens exposed to Marek's disease virus: inhibition of activity in susceptible chickens and enhancement of activity in resistant and vaccinated chickens. Avian Dis. 1981; 25:882–893.
Article
35. Van Immerseel F, De Buck J, De Smet I, Mast J, Haesebrouck F, Ducatelle R. The effect of vaccination with a
Salmonella Enteritidis
aroA mutant on early cellular responses in caecal lamina propria of newly-hatched chickens. Vaccine. 2002; 20:3034–3041.
Article
36. Venugopal K. Marek's disease: an update on oncogenic mechanisms and control. Res Vet Sci. 2000; 69:17–23.
Article
37. VonBülow V, Weiler H, Klasen A. Activating effects of interferons, lymphokines and viruses on cultured chicken macrophages. Avian Pathol. 1984; 13:621–637.
Article
38. White DW, Keppel CR, Schneider SE, Reese TA, Coder J, Payton JE, Ley TJ, Virgin HW, Fehniger TA. Latent herpesvirus infection arms NK cells. Blood. 2010; 115:4377–4383.
Article
39. Xing Z, Schat KA. Inhibitory effects of nitric oxide and gamma interferon on in vitro and in vivo replication of Marek's disease virus. J Virol. 2000; 74:3605–3612.
Article
40. Xu M, Fitzgerald SD, Zhang H, Karcher DM, Heidari M. Very virulent plus strains of MDV induce an acute form of transient paralysis in both susceptible and resistant chicken lines. Viral Immunol. 2012; 25:306–323.
Article
41. Yokoyama WM, Kim S, French AR. The dynamic life of natural killer cells. Annu Rev Immunol. 2004; 22:405–429.
Article